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Abstract
Background: In the United States, more people die from drug overdoses related to increased
heroin and fentanyl use than homicides and car accidents combined (Sederer & Marino, 2018).
Frustrations and negative perceptions (stigma) on behalf of primary healthcare providers may
result in negative health outcomes for patients, poor therapeutic relationships and lack of
opportunity to engage clients in substance use treatment (Khenti et al., 2017).
Purpose: The purpose of this project was to implement a contact-didactic education module to
improve adult gerontology primary care (AGPCNP) and family nurse practitioner (FNP)
students’ attitudes towards OUD patients, and to increase their therapeutic commitment to and
confidence in working with patients seeking primary care treatment with co-occurring opioid use
disorders.
Methods: The project utilized a pre and post-test design. The Drug and Drug Problems
Questionnaire (DDPPQ) and a nurse practitioner confidence scale (NPCS) were administered pre
and post intervention to AGPCNP and FNP students finishing their second year of a Doctor of
Nursing Practice (DNP) program.
Significance: The implemented education module resulted in statistically significant decrease in
scores on the DDPPQ, indicating reduced stigma, and increased NPCS scores indicating
increased confidence. A statistically significant inverse correlation was noted between NPCS
scores and DDPPQ scores.

Keywords: opioid use disorder, substance use disorder, primary care, stigma, social capital,
attitudes, nursing education, therapeutic relationship
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Increasing the Confidence of Primary Care Nurse Practitioner Students in Caring for Patients
with Preexisting Opioid Use Disorder
Background and Significance
The opioid crisis in the United States continues and opioid related mortality rates
nationwide remain staggering. With an increase in opioid use comes comorbid illnesses. The
combined impact leads to greater interaction with healthcare providers in primary care clinics,
including adult-gerontology primary care (AGPCNP) and family nurse practitioners (FNP), who
are increasingly prominent in the healthcare workforce. This increased interaction with health
care providers presents an opportunity to improve the response to the opioid crisis and increase
the skills and knowledge needed to care for these individuals.
In 2013, 4.3 million persons aged 12 and older had an illicit drug use disorder (Crowley
& Kirschner, 2015). By 2016, this number had increased to 7.4 million people, with 2.1 million
of these individuals having an opioid use disorder (Ahrnsbrak, Bose, Hedden, Lipari, & ParkLee, 2017). This is a substantial increase in just a three-year timeframe. An estimated 142 people
in the U.S. die from drug overdoses every day, due to the increased use of heroin and fentanyl
additives; more than motor vehicle accidents and homicides combined (Sederer & Marino,
2018). Risk of mortality for individuals with opioid use disorders have risen to 20 times higher
than that of the general population, and opioid mortality rates in general have skyrocketedparticularly with the surge in prescription opioid misuse over the last 20 years (Watkins, et al.,
2017). This spike is alarming, and the numbers suggest the problem becoming more widespread
throughout the United States.
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Kentucky is tied for third highest in deaths related to drug overdose per capita nationwide
(Hauser, 2017). Rates of overdose fatalities in the state of Kentucky reached 1,404 as of June
2017; and Jefferson county had the most overdose deaths of any county in the state (Tilley &
Ingram, 2018). The Louisville Metro area has been particularly hard hit. In early February of
2017, there was a 32-hour period during which Emergency Medical Services (EMS) responded
to approximately two overdose calls per hour; annual instances of EMS calls for overdose had
risen to 6,879 in 2016 (Hauser, 2017). Beyond this alarming trend, as a result of the increase in
intravenous (IV) drug use, out of 220 counties in the entire United States with increased
vulnerability to Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV)
dissemination, 54 of these were in Kentucky (Centers for Disease Control and Prevention
[CDC], 2018).
While overdose rates are obvious, comorbid conditions related to long-term OUDs are
often overlooked by the general public as well as the healthcare industry. These comorbid
illnesses are debilitating and often require medical attention or hospitalization- they run the
gamut from injection site infections and abscesses to HIV and HCV. It is worth noting here that
OUDs are a subset of general SUDs and, while the research often broadens the scope to examine
SUDs in general, for the purposes of this paper the terms will be used interchangeably as the
stigma and disease process components are equally relevant. The rise of the opioid epidemic has
led to increased contact with the medical community as these patients seek or require treatment
for complications related to persistent opioid use (Dion, 2015). This increase in medical
intervention, particularly in primary care settings, presents an opportunity for AGPCNPs and
FNPs to intervene.
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Unfortunately, healthcare providers often hold prejudiced views towards OUD patients.
This is not exclusive to AGPCNPs and FNPs; however. According to van Boeckel, Brouwers,
Weeghel, and Garretsen (2013), healthcare professionals who do not specialize in addiction,
when compared to psychiatrists and addiction specialists, are more likely to view OUD as a
character flaw and not a medical problem, and had the lowest regard for working with this
population. This is problematic if the hope is for the medical community to intervene and reduce
the impact of this epidemic. These challenges can lead to poor patient outcomes, lower patient
satisfaction scores, frustrated staff, as well as missed opportunities for meaningful and effective
intervention.
Stigma is among the most pervasive, yet least discussed, issues facing healthcare today. It
is considered to be a mark of shame and disqualifying characteristic concerning an individual in
the eyes of a larger group. Stigma is based in social relationships and pervades all levels of
culture (Pescosolido & Martin, 2015). This means that nobody is immune to stigma, and every
member of society is impacted in some way. The process by which this occurs consists of the
labelling of a stigmatized group, and the association of said labels with other negative qualities;
these individuals are thus given a lower social status (Kennedy-Hendricks et al., 2017). While
stigma touches the life of every person in a society, there are groups who tend to be
disproportionately affected. As stigma is a function of society and culture, it necessarily varies
based on these norms changing over time. At present, however, chief among those
disproportionately affected are patients with mental health disorders and, specifically,
SUDs/OUDs. There were three million federal and state prison admissions between 2003 and
2011 related to or involving illicit substances, and this contributes to the stigmatization of SUD
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as moral weakness rather than a medical disorder requiring health care intervention (Wakeman &
Rich, 2018).
Most healthcare professionals enter the field with high ideals or, at the least, good
intentions. Healthcare providers are not immune to stigmatizing beliefs or behaviors. While
stigma of persons with substance use disorders is widespread, in health care settings this stigma
leads to missed opportunities to assist the patient in attaining improved health outcomes (Khenti
et al., 2017). Stigma among primary healthcare providers in care provision for persons with
opioid use disorders can lead to frustration among the providers and negative outcomes for the
patients (van Boekel, Brouwers, van Weeghel, & Garretsen, 2013; Dion, 2015). It is important to
note, however, that research demonstrates that it is possible to reduce stigma and increase nurse
practitioner confidence in providing care for this population.
In general, people are far more likely to hold negative beliefs and attitudes toward
individuals with SUDs when compared to other emotional or mental health issues (Henderson &
Dressler, 2017). It therefore stands to reason that patients with OUD, having experienced stigma
in life, will anticipate it in seeking help. Unfortunately, the research suggests that stigma
continues to be demonstrated towards patients with OUDs in healthcare settings across the
United States. Stigmatization in healthcare settings has a range of poor patient outcomes, from
coercive treatment of this patient population, to being provided with insufficient information, to
patronization and humiliation (Khenti et al., 2017).
Patients experiencing SUDs and OUDs may avoid seeking treatment or assistance from
the medical community as a result of the stigma they live with day-to-day (Henderson &
Dressler, 2017). The complications associated with stigma are often internalized, leading to poor
self-esteem, and, as a result, lower levels of social functioning (Ersöğütçü & Karakas, 2016).
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Self-stigmatization creates a self-fulfilling and detrimental cycle as increased stigma leads to
decreased social functioning, which can reinforce and worsen stigma. According to Kulesza,
Watkins, Ober, Osilla, and Ewing (2017), there is evidence to suggest that internalized stigma is
positively correlated with substance use problems in primary care patients, as well as poor health
outcomes in general.
The opioid crisis is multi-faceted and complex. The engagement of health care providers
will be an imperative piece of any initiative to combat the situation. The prejudices and
frustration on behalf of primary healthcare providers is important to address for that very reason.
Some of these prejudices are difficult to quantify, but the evidence supports that many of these
issues can be addressed through contact with persons who are successful in recovery, resulting in
stigma reduction and increased provider confidence.
Problem Statement
OUD’s are on the rise across the country and this has led to increased contact with
general practitioners. As adult gerontology primary care and family nurse practitioners have a
larger role in the primary care workforce, there has been increased contact between these
providers and persons with OUDs as they seek treatment for comorbid medical conditions. A
lack of understanding of OUDs or effective communication strategies to successfully employ can
lead to stigmatic views towards persons experiencing OUDs and a lack of therapeutic
commitment. Therapeutic commitment is an inclination towards providing therapeutic care to
patients with OUDs. The stigma experienced by this population in dealing with primary care
providers then dissuades the seeking out of healthcare, ignores an opportunity for meaningful
intervention, perpetuates the cycle of stigma and continued negative outcomes for the individual,
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the family and the community. This state of affairs cannot continue if the medical community
hopes to intervene concerning the opioid crisis and save lives.
Summary of Evidence
Electronic databases CINAHL, Medline via PubMed, and Psycinfo were searched
utilizing the keywords: opioid use disorder, substance use disorder, stigma, social capital,
attitudes, nursing education, and therapeutic relationship in various combinations. The articles
that were selected focused on either stigma, were related to SUD, OUD, and mental illness, or
addressed successful methods in addressing stigma and negative attitudes towards SUD, OUD,
or mental illness. All 30 articles included were published in the last twenty-three years, with 24
of these in the last six years. The articles consisted of descriptive, qualitative, meta analyses, and
cohort studies. Additionally, there was one doctoral dissertation included and a PowerPoint
presentation concerning effective communication techniques.
Educational Interventions
The research supports the notion that the implementation of a mixed methods training
program focusing on communication strategies, biopsychosocial, and sociocultural aspects of
SUDs/OUDs with additional contact-based education could reduce stigma and increase
confidence levels in providing care for patients with co-occurring OUD/SUD. It also underscores
the negative impact that stigma has on this population and the negative health outcomes
associated therewith.
There is strong evidence to suggest that the contact-based education approach, is a critical
component in addressing the issue of stigma among healthcare providers. Contact-based
education utilizes contact with a representative of the population to glean insight into the lived
experience of the broader population he/she represents. In this project, a healthcare professional
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living with and managing a substance use disorder provided education on stigma and OUDs.
According to the National Academies of Sciences, Engineering, and Medicine, (2016), the
evidence shows a consistent inverse relationship between contact interventions and levels of
stigma. A meta-analysis completed by Corrigan, Michaels, Rafacz, and Rusch (2012),
demonstrated that effect sizes for contact-based education and trainings on attitude change and
intended behaviors were twice those which utilized education alone. The notion that people who
are living with and successfully managing mental or substance use disorders are extremely
potent resources in reducing stigma has been validated in numerous research studies, and this
paradigm for delivering a message has proven to be extremely powerful in promoting empathyhelping lessen or eliminate stigma on behalf of the target audience (National Academies of
Sciences, Engineering, and Medicine, 2016).
Stigma and Bias
Capurso and Shorter (2017) discussed the belief that mental illness and substance use
disorders are moralistic rather than biological concerns as contributory to stigma, and a
substantial bias to be overcome. Furthermore, according to Bartlett, Brown, Shattell, Wright, and
Lewallen (2013), recognizing substance use disorders as a disease like any other will be
imperative to the alleviation of stigma and, indeed, any progress towards alleviation of the
condition itself. Emphasizing the neurological changes that occur in the brain with OUD’s
provided a scientific framework through which to view the condition and provide a rationale for
a scientific, as opposed to moralistic, appraisal of the condition.
Biopsychosocial Education
The biopsychosocial issues related to substance use disorders and communication
strategies have been identified as important points for education and training as it relates to
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improving nurse confidence levels (Nash et al., 2017). A study by Anda et al., (2006), illustrated
the link between adverse childhood experiences and the development of substance use disorders,
with four or more of these experiences strongly correlated to IV drug use in adulthood. This type
of biopsychosocial training module has also demonstrated efficacy in stigma reduction.
According to Griffiths, Carron-Arthur, Parsons, and Reid (2014), there was a statistically
significant reduction in stigma resulting from educational interventions even when performed
alone across a variety of mental health conditions. Furthermore, a recent Harvard study
recommended didactic education in attempting to improve attitudes among psychiatric residents
towards SUD patients (Avery & Zerbo, 2015).
Communication Techniques
Communication techniques, specifically those incorporating motivational enhancement,
have been effective in improving nurse-patient interactions with patients experiencing
OUD/SUD (Fornili, Burda & Selby, 2018). Motivational enhancement techniques enable
healthcare workers to meet the patient where he/she is regarding readiness to change behavior
and maximize the motivation to move towards this behavior change. Approaching patients in a
therapeutic manner is imperative if we hope to combat the opioid crisis. There is evidence to
suggest that even if patients are not amenable to receiving information about drug treatment or
are not interested in stopping substance use at the time of hospitalization, they will reap positive
benefit by simply having the subject approached in a compassionate manner with information
about treatment options provided (Bartlett et al, 2013).
Theoretical Framework
This education intervention was guided by the Framework Integrating Normative
Influences on Stigma (FINIS) (Pescosolido & Martin, 2015). FINIS considers the factors that
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drive stigma, most basically, as the interface between individual and community influences.
There are three levels of influence, micro, meso and macro. The micro level involves
psychological and sociocultural factors on the individual level- the individual AGPC/FNP. The
meso level includes social networks and organizations, the healthcare and professional
environment. The macro level consists of society wide factors, historical, media and policy
environment. These set the process of stigmatization in motion and define the creation and
maintenance of stigma across a host of avenues.
FINIS helped focus this intervention on two of these levels: micro and meso
(Pescosolido, Martin, Lang, & Olafsdottir, 2008). It is a bottom to top approach beginning at a
largely grassroots level with the hope of influencing attitudes and increasing knowledge levels
specifically at a point where individual and community influences converge and coexist. Stigma
is a phenomenon of social norms, relationships, and culture, so it is necessary for solutions
seeking to address stigma to focus on social relationships and the structures underpinned by these
stigmatic views (Pescosolido & Martin, 2015). In the case of this intervention, these structures
and relationships consisted of the primary healthcare provider (specifically, the AGPCNP and
FNP students) as representatives of the healthcare system on the meso level and the patientprovider relationship on the micro or individual level.
Purpose
The purpose of this quality improvement project was to implement a contact-education
training on OUDs, with the goal of reducing stigma among ACPCNPs and FNPs students who
will be entering practice in primary care and caring for patients with co-occurring OUDs.
Additionally, objectives included an increase in therapeutic commitment to and an improvement
of attitude towards patients with comorbid OUD. Increased therapeutic commitment and
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improved attitudes towards working with patients with co-occurring OUDs increase the
likelihood of patients with OUDs receiving compassionate care and being guided towards
positive health care outcomes. Improved understanding of addiction, with improved
communication and confidence may result in a more empathetic and accessible health care
system.
Methods
Setting and Organizational Assessment
The setting was a class session in the course on Mental Health in Primary Care for FNP
and AGPCNP students at a southeastern, metropolitan university in a DNP program.
Participants
The target population was graduate nursing students attending a course on mental health
in primary care for AGPCNP and FNP students in the sixth semester of a three-year DNP
program. Exclusion criteria included enrollment in another specialty not focused on primary
care. There was no requirement of any kind to participate in the survey, and this was made clear
prior to survey distribution to all participants. All 17 students participated in the class as part of
the requirement for the course, but completion of the surveys was strictly voluntary.
Intervention
The education module took 100 minutes and was divided into short teaching segments as
follows: 10 minutes for initial survey completion, 30 minutes for the contact-based component,
30 minutes for the didactic component, 20 minutes to practice the communication techniques,
and 10 minutes to administer the post test. The contact-based component of the intervention
consisted of a brief presentation on OUD by a registered nurse who was successfully living with
and managing SUD. The contact-based presentation reviewed the typical presentation of persons
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with OUD/SUD and their similarity to other chronic conditions that are often similar to issues
with periods of remission and exacerbation or adherence (e.g., diabetes and chronic obstructive
pulmonary disease). Issues surrounding the resources available to a patient with OUD were also
reviewed. The speaker presented her background with SUD, and she emphasized the importance
of instilling hope and providing resources. This gave the participants the opportunity to connect
with the human face of addiction and the importance of compassionate care in helping persons of
OUD lead healthy lives.
The didactic presentation considered OUD from a biopsychosocial perspective- it was
solution-oriented, connecting current health and social issues with continued substance use, an
emphasis on harm reduction strategies, and practice with communication strategies to promote a
non-judgmental relationship. The biological components centered on the concepts of tolerance,
withdrawal and delay discounting, specifically as they relate to behaviors in seeking primary care
treatment in this patient population. Delay discounting refers to the extent to which a given
reward loses perceived value based on the length of time it will take to acquire it. It is a
phenomenon often augmented in patients who are dealing with OUD (Karakula et al., 2016). In
decision making processes, the immediacy in receiving the reward weighs heavily (Matta,
Gonçalves, & Bizarro, 2012). An example of delay discounting is in one spending money on an
expensive car to be enjoyed right away as opposed to saving for a more comfortable retirement
later. For patients with OUD however, an increase in delay discounting can lead to the sacrifice
of physical health, or risk legal involvement in the acquisition of the reward.
The delay discounting and presentation of behaviors as motivated by tolerance and
withdrawal issues incorporate the biological and psychological factors inherent in the
biopsychosocial model. The main psychological focus, however, dealt with the link between
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adverse childhood experiences (ACEs), trauma history and SUDs/OUDs. According to Anda et
al., (2006), there is a direct correlation between having four or more ACE’s and substance use
risk, particularly as it relates to IV drug use. Heritability of trauma and its impact on risk for
psychological problems in offspring was also touched on, as described by Santavirta, Santavirta,
and Gilman, (2017). Understanding the link between traumatic events in childhood and
SUD’s/OUD’s allows a more humanistic and empathetic view of these conditions to develop.
This also ties into the social determinants of the development of SUD/OUD.
Communication strategies were demonstrated and practiced among the participants.
Motivational enhancement is a communication strategy of meeting people where they are in
terms of their readiness for change (Fornili, Burda, & Selby, 2018). The two key tenets of
motivational enhancement are to avoid pushing someone who is not ready to change and to
gently prepare them for change. The specific motivational enhancement techniques that were
covered included the elicitation of self-motivating statements, affirming the patient, and handling
resistance. Eliciting self-motivating statements is a technique designed to get patients to state
their own reasons for behavior change as opposed to telling the patient what to do; affirming the
patient involves finding opportunities to reinforce the patient and, in particular, his/her
motivation to strengthen the relationship and contribute to patient empowerment; handling
resistance consists of strategies to effectively respond to patient resistance when discussing
issues with OUD (Miller, Zweben, DiClemente, & Rychtarik, 1995). A handout with key points
about these techniques was provided to the participants (see Appendix E).
Participants were given a pamphlet with information about treatment options and
resources for homelessness, OUD and SUD (Ice House Inc., n.d.).that could be distributed to
their patients. This provides patients with information about treatment options, and served as a
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resource for AGPCNP/FNP students to have a greater knowledge of the local programs and
supports available to improve the individual patient experience as well as the greater opioid
crisis.
Ethical Considerations and Institution Review
This was a quality improvement project reviewed by the University of Louisville
Institutional Review Board and deemed not human subjects research. Therefore, the project did
not require full IRB review. There was no identifying information collected, and all institutional
guidelines were followed.
Project Design
A pretest-post test design was used for this project.
Measures
The Drugs and Drug User’s Problems Perceptions Questionnaire (DDPPQ) was used to
measure student attitudes and therapeutic commitment towards working with OUD patients (see
Appendix A). The DDPPQ is a 22-item survey, derived from the original alcohol and alcohol
problems perceptions questionnaire (AAPPQ) and measures attitude towards working with and
therapeutic commitment towards SUD patients. The scale utilizes a 7-point Likert scale to rank
the extent of their agreement with a series of questions about work with SUD patients, with 1
meaning “strongly agree” and 7 meaning “strongly disagree”. Lower scores mean more positive
outlooks, and higher scores mean more negative outlooks.
The DDPPQ demonstrated acceptable test-retest reliability (p=0.14) and good internal
consistency with an alpha coefficient of 0.87 (Watson, MacLaren, & Kerr, 2007). The DDPPQ
contains five component subscales. Component 1 consists of seven items related to role
adequacy and has an alpha coefficient on 0.94 (Watson, MacLaren, & Kerr, 2007). Component 2
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consists of three items related to role support, and has an alpha coefficient of 0.78 (Watson,
MacLaren, & Kerr, 2007). Component 3 consists of four items related to job satisfaction with an
alpha coefficient of 0.80 (Watson, MacLaren, & Kerr, 2007). Component 4 consists of four items
concerning role-related self-esteem and has an alpha coefficient of 0.69 (Watson, MacLaren, &
Kerr, 2007). Component five consists of two items related to role legitimacy, and has an alpha
coefficient of 0.89 (Watson, MacLaren, & Kerr, 2007).
The participants also completed an Adult Gerontology Primary Care and Family Nurse
Practitioner Confidence in Caring for Persons Experiencing OUD Scale (NPCS) developed by
the author for this project (see Appendix B). This measured AGPCNP and FNP confidence level
in care provision to persons with co-occurring OUD in five specific domains. These included
approaching patients with OUDs about their condition, engaging in motivational enhancement
techniques, instilling hope, providing resources and maintaining a therapeutic mindset. The scale
utilized a 5-point Likert scale with 1 being “not at all confident” and 5 being “totally confident”.
A process evaluation was completed following the presentation of the education modules
(see Appendix C). The purpose of the process evaluation was for the students to rate the
presenters and efficacy of the intervention in meeting three primary objectives: examining the
importance of stigma reduction in caring for SUD/OUD patients by AGPCNP/FNP’s,
demonstrating motivational enhancement communication techniques for use with clients with
OUD/SUD, and discussing practices and resources to increase confidence in care provision for
clients with OUD/SUD. This was rated on a 4-point Likert scale with 1 being “strongly disagree”
and 4 being “strongly agree”.
The demographic information sheet was completed (see Appendix D). This contained
questions to collet non-identifying, demographic data including age, race, gender, current
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position, years in current position, years in nursing related field, prior experience in mental
health or substance use treatment, and highest degree completed.
Data Collection
At the beginning of the class session, all participants received a numbered packet
containing the DDPPQ, Adult Gerontology Primary Care and Family Nurse Practitioner
Confidence in Caring for Persons Experiencing OUD Scale. The participants completed these
measures as well as the demographic data. The completion of these scales provided the baseline
prior to the intervention. The educational intervention, both didactic and contact-based
components, was then presented. Immediately following the intervention, the participants
received a second packet with the DDPPQ, AGPC/FNP Confidence in Caring for Persons
Experiencing OUD Scale, and the process evaluation form. These packets were numbered
corresponding to the original packets. There was no identifying information associated with the
responses. The survey responses were kept in a locked office at the University of Louisville
Health Science Campus, with electronic copies of the information kept securely on an encrypted
laptop computer. All HIPAA policies and procedures were followed.
Data Analysis
Data analysis was performed using SPSS v.22. Descriptive statistics were used to
summarize demographic and clinical characteristics. Paired t-tests were used to examine the
impact of the intervention on the DDPPQ and NPCS participant scores. Pearson Product Moment
Correlation was used to determine the relationship among the dependent variables and
demographic characteristics.
Results
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There were 17 total participants (N=17) for this intervention. The majority of participants
were 20-30 years old (n = 10; 58.1%), Caucasian (n = 15; 88%), and identified as female (n = 16;
94%). All were BSN prepared and enrolled in the Family Nurse Practitioner track or the AdultGerontology Primary Care Nurse Practitioner track of the DNP program. The majority of
participants worked in nursing for six years or less (n = 12; 70.6%). Approximately, one-third (n
= 6; 35%) had past mental health or substance use disorder related work experience.
A paired-samples t-test was conducted to evaluate the impact of the intervention on
participants’ scores on the DDPPQ. There was a statistically significant decrease in DDPPQ
scores from Time 1 (M=77.75, SD=22.65) to Time 2 (M=55.75, SD= 18.25), t (4.45), p <.01
(two-tailed). The mean decrease in DDPPQ scores was 22 with a 95% confidence interval
ranging from 11.45 to 32.55 (Table 1).
The six subscales were also analyzed utilizing paired-samples t-tests to evaluate the
impact of the intervention on participants’ scores on the respective subscales (Table 1). A pairedsamples t-test was conducted to evaluate the impact of the intervention on participants’ scores on
the DDPPQ subscale related to role adequacy (subscale 1). There was a statistically significant
decrease in subscale 1 scores from Time 1 (M=29.24, SD=6.25) to Time 2 (M=20.65, SD=6.61),
t (4.82), p < .01 (two-tailed). The mean decrease in subscale 1 scores was 8.59 with a 95%
confidence interval ranging from 4.81 to 12.37.
A paired-samples t-test was conducted to evaluate the impact of the intervention on
participants’ scores on the DDPPQ subscale that deals with role legitimacy (subscale 2). There
was a statistically significant decrease in subscale 2 scores from Time 1 (M=8.06, SD=3.38) to
Time 2 (M=5.94, SD=2.83), t (3.57), p < .01 (two-tailed). The mean decrease in subscale 2
scores was 2.12 with a 95% confidence interval ranging from .86 to 3.38.
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A paired-samples t-test was conducted to evaluate the impact of the intervention on
participants’ scores on the DDPPQ subscale that deals with role support (subscale 3). There was
a decrease in subscale 3 scores from Time 1 (M=14.47, SD=15.44) to Time 2 (M=7.06,
SD=3.70), t (2.06), p .056 (two-tailed). The mean decrease in subscale 3 scores was 2.12 with a
95% confidence interval ranging from .86 to 3.38. This result was not statistically significant.
A paired-samples t-test was conducted to evaluate the impact of the intervention on
participants’ scores on the DDPPQ subscale that deals with motivation (subscale 4). There was a
statistically significant decrease in subscale 4 scores from Time 1 (M=3.29, SD=1.50) to Time 2
(M=2.65, SD=1.41), t (3.10), p < .05 (two-tailed). The mean decrease in subscale 4 scores was
0.65 with a 95% confidence interval ranging from .20 to 1.10.
Subscale 5 dealt with role-related self-esteem. There was a decrease in subscale 5 scores
from Time 1 (M=8.89, SD=3.35) to Time 2 (M=7.65, SD=3.41), t (1.84), p .09 (two-tailed). The
mean decrease in subscale 5 scores was 1.24 with a 95% confidence interval ranging from -.19 to
2.66. This decrease was not statistically significant. Subscale 6 concerned work satisfaction, and
there was a decrease in subscale 6 scores from Time 1 (M=14.19, SD=5.04) to Time 2
(M=11.88, SD=5.06), t (1.87), p .08 (two-tailed). The mean decrease in subscale 6 scores was
2.31 with a 95% confidence interval ranging from -.32 to 4.94. This result was not statistically
significant.
A paired-samples t-test was conducted to evaluate the impact of the intervention on participants’
scores on the NPCS. There was a statistically significant increase in NPCS scores from Time 1
(M=15.18, SD=3.56) to Time 2 (M=20.94, SD= 2.41), t (-9.10), p <.01 (two-tailed). The mean
increase in NPCS scores was -5.76 with a 95% confidence interval ranging from -7.11 to -4.42.
Table 1
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Mean Total Pre and Post Intervention Scores for DDPPQ, DDPPQ Subscales and NPCS

DDPPQ**

Role Adequacy**

Pre

Post

Confidence

Education

Education

Interval

Session

Session

Mean (SD)

Mean (SD)

77.75

55.75

(22.65)

(18.25)

29.24

t value

Sig. (2tailed)

11.45-32.55

4.45

<.001

20.65 (6.61)

4.81-12.37

4.82

<.001

8.06 (3.34)

5.94 (2.84

.86-3.38

3.57

.003

14.47

7.06 (3.70)

-.20-15.02

2.06

.056

(6.25)
Role Legitamcy*
Role Support

(15.44)
Motivation*

3.29 (1.49)

2.65 (1.41)

.20-1.09

3.10

.007

Role-related Self-

8.88 (3.35)

7.65 (3.41)

-.19-2.66

1.83

.085

14.19 (5.04)

11.88 (5.06)

-.32-4.94

1.87

.081

15.06

20.88

-7.25 - -4.38

-8.65

<.001

esteem
Role Support
NPCS**

* Correlation is significant at the 0.05 level (two-tailed)
** Correlation is significant at the 0.01 level (two-tailed)
Other variables were analyzed for correlation among pre and post measures. These
variables included age, gender, years in current role, and years of prior mental health experience.
There was a strong positive correlation between age and NPCS pretest scores (r=.596 n=17
p<.05) with increased age correlated with increased levels of nurse practitioner initial confidence
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in providing care for patients with co-occurring OUD (Table 2). None of the other analyses
demonstrated significant correlations.
Table 2
Correlation Among Pre and Post DDPPQ and NPCS and Prior MH/SUD Experience
1

2

3

4

1. DDPPQ Pretest

--

2. DDPPQ Posttest

.549*

--

3. NPCS Pretest

-.293

-.136

--

4. NPCS Posttest

-.354

-.483*

.679**

--

5. Prior MH/SUD

.009

-.150

.497*

.334

5

--

Experience
* Correlation is significant at the 0.05 level (two-tailed)
** Correlation is significant at the 0.01 level (two-tailed)

Of the 17 total participants, 15 completed the post session evaluation. The majority of
participants strongly agreed that the objectives were met: 93.3% strongly agreed that examining
the importance of stigma reduction was met; 80% strongly agreed that motivational enhancement
techniques were demonstrated; 93.3% of participants strongly agreed that practices and resources
to increase confidence in care provision were discussed. All of the participants who completed
the post session evaluation (n=15) indicated that all three objectives were met.
A latent content analysis was completed based on elements of the intervention as codes.
Of the 17 participants who completed a pre-test, ten provided comments. There were 21
comments made by the respondents. These fell into three main categories: general comments,
most helpful, and areas for improvement. There was only one general comment which was “very
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friendly and interactive”. Regarding the most helpful category, there were three main elements
identified: case studies, contact, and resources. There were four respondents who identified case
studies as being most helpful; one stated “The case studies were helpful in sparking discussion
and helping to cement ideas that were presented.” Contact was identified as most helpful by four
respondents; one identified the “real world experiences.” The resources provided were identified
as most helpful by three respondents. One respondent also identified the motivational
enhancement techniques as most helpful, while another identified the statistics related to the
opioid crisis.
The comments on suggestions for improvement were more varied. Areas of improvement
were: implementation of early identification strategies; pictures and images of patients with
OUD/SUD to demonstrate the physical toll these conditions take; and an increase
attention/practice in motivational enhancement techniques. Two comments confirmed the
usefulness and satisfaction with the session with comments to improvement of “None”, and “Do
it for all nursing students”.
Discussion
This project demonstrated that a mixed-methods contact-didactic education intervention
yielded a reduction in stigma and an increase in nurse practitioner student confidence in
providing care for patients with co-occurring OUD. The decrease in stigma was demonstrated in
the statistically significant reduction in mean DDPPQ scores post intervention. Further, there was
also a statistically significant negative correlation noted between nurse practitioner confidence
levels as measured by the NPCS, and stigma as measured by the DDPPQ. Suggesting that as the
confidence level in the practitioner rose, stigma associated with drug addiction decreased. These
findings support the literature in which Griffiths et al. (2014) described a statistically significant
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reduction in stigma regarding mental illnesses even after a single educational intervention.
Conversely, the mean scores on the NPCS (confidence measure) had a statistically significant
increase after the intervention. The participants identified as most helpful the contact-based
component, the case studies, and the resources provided.
This project did not find a significant difference in pre or post intervention levels of
stigma being associated with increased contact with OUD patients as determined by having
responded affirmatively to prior MH/SUD experience. This contradicts the findings from van
Boeckel et al., (2013) who found a relationship between those working in psychiatry and
addiction specialists and having higher regard for patients with SUDs. This could be the result of
these participants having been in graduate school working towards advanced practice nursing
degrees whereas the aforementioned study focused on providers. It should also be noted that no
respondent was a practitioner at the time of the intervention whereas the population in the van
Boeckel study consisted of providers and did not take place in academia. The intervention in this
project framed OUD as a medical condition similar to other diseases subject to exacerbation and
remission. The reduction in stigma that resulted from this intervention is consistent with the
work of Capurso and Shorter, (2017) who found that moralistic as opposed to medical views of
addictive disorders contributed to stigma.
Limitations
There were several limitations to this quality improvement project. The sample size was
small and consisted only of educated participants in an academic setting, which could reduce
initial rates of stigma. The sample was also relatively homogenous in terms of racial/ethnic
background and gender. The results were not generalizable to other settings as the sample was
not representative of the population at large. The measure to assess nurse practitioner’s

STIGMA, OPIOID USE DISORDERS, AND PRIMARY CARE NP STUDENTS

27

confidence was developed for this project, so the psychometric properties of this scale have not
been examined. The intervention itself was also comparatively brief and there were no
mechanisms in place to assess or monitor the impact of the educational intervention over the
long term. The NPCS was designed by the author for this specific intervention and not a
validated instrument.
Conclusion
This project demonstrated the efficacy of utilizing a mixed-methods contact-didactic
education module to both increase primary care nurse practitioner confidence and reduce stigma
towards primary care patients with co-occurring OUD. The intervention was carried out in 100
minutes and all participants agreed that the three objectives were met. Understanding the
importance of stigma reduction in providing care to primary care patients with co-occurring
OUD, and more broadly, in combating the opioid epidemic, the utility of this intervention in
taking meaningful steps to accomplish these aims is clear.
The intervention utilized in this project could be readily implemented into the regular
curriculum for AGPC/FNP students. There was no cost associated with the intervention itself,
and the material is relevant to a broader understanding of addictive disorders. Moving forward,
the population could be broadened to include undergraduate nursing students in an academic
setting, or floor nursing staff in a clinical setting. It is also worth noting that the NPCS could be
validated as an instrument to measure confidence in primary care nurse practitioners or other
primary healthcare workers.
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Appendix A: DDPPQ
Drug and Drug Problems Perception Questionnaire (DDPPQ)

Please circle one number for each question.
1. I feel I have a working knowledge of
drugs and drug related problems.
2. I feel I know enough about the causes
of drug problems
3. I feel I know enough about the
physical effects of drug use to carry
out my role when working with drug
users.
4. I feel I know enough about the
psychological effects of drug use to
carry out my role when working with
drug users.
5. I feel I know enough about the factors
which put people at risk of developing
drug problems to carry out my role
when working with drug users.
6. I feel I know how to counsel drug
users over the long term.
7. I feel I can appropriately advise my
patients about drugs and their effects.
8. I feel I have the right to ask patients
questions about their drug use when
necessary.
9. I feel that my patients believe I have
the right to ask them questions about
their drug use when necessary.
10. I feel I have the right to ask a patient
for any information that is relevant to
their drug problems.
11. If I felt the need when working with
drug users I could easily find someone
with whom I could discuss any
personal difficulties I might encounter.
12. If I felt the need when working with
drug users I could easily find someone
who would help me clarify my
professional responsibilities.
13. If I felt the need I could easily find
someone who would be able to help

Strongly
Agree
1
2

Strongly
Disagree
6
7

3

4

5

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7
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me formulate the best approach to a
drug user
14. I want to work with drug users
15. I feel that there is little I can do to help
drug users.
16. In general, I have less respect for drug
users than for most other patients I
work with.
17. I feel I do not have much to be proud
of when working with drug users.
18. At times I feel I am no good at all with
drug users.
19. On the whole, I am satisfied with the
way I work with drug users.
20. In general, one can get satisfaction
from working with drug users.
21. In general, it is rewarding to work
with drug users.
22. In general, I feel I can understand drug
users.
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1
1

2
2

3
3

4
4

5
5

6
6

7
7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7
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Appendix B: Adult Gerontology Primary Care and Family Nurse Practitioner Confidence
in Caring for Persons Experiencing OUD Scale
Adult Gerontology Primary Care and Family Nurse Practitioner Confidence in Caring for
Persons Experiencing OUD Scale
(For the following situations, please circle one answer choice only on a scale of 1-5 where 1
means “not at all confident”, and 5 means “totally confident”)
1. Approaching patients with opioid use disorders about their condition(s).
1

2

3

4

Not at all confident

5
Totally confident

2. Engaging in motivational enhancement techniques with patients with opioid use disorders
1

2

3

4

Not at all confident

5
Totally confident

3. Instilling hope in patients with opioid use disorders.
1
2
Not at all confident

3

4

5
Totally confident

4. Providing resources or referring patients with opioid use disorders.
1

2

3

4

Not at all confident

5
Totally confident

5. Maintaining a therapeutic mindset when providing care for patients with opioid use
disorders.
1
Not at all confident

2

3

4

5
Totally confident
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Appendix C: Process Evaluation

UNIVERSITY OF LOUISVILLE
SCHOOL OF NURSING
Increasing the Confidence of Adult Gerontology Primary Care and Family Nurse
Practitioner Students in Caring for Patients with Preexisting Opioid Use Disorder
Please provide feedback regarding this educational presentation. Please indicate the level of
agreement with the following statements regarding this presentation.
Objectives:

STRONGLY AGREE DISAGREE STORNGLY
AGREE
DISAGREE
4
3
2
1

Met objective: Examine the
importance of reducing stigma in
caring for clients with SUD/OUD by
AGPCNP/FNP students.
Met objective: Demonstrate
motivational enhancement
communication techniques for use
with clients with SUD/OUD
Met objective: Discuss practices and
resources to increase confidence in
caring for clients with SUD/OUD by
AGPCNP/FNP students.

Addressed the objectives
Was clear in presentation
Addressed the objectives
Was clear in presentation

4

3

2

1

4

3

2

1

3
3

2
2

1
1

3
3

2
2

1
1

Amy Spain-Duncan
4
4
Chris Hannon
4
4

Please provide comments regarding this presentation:
Most helpful aspect of this presentation:

Recommendations for improvement of this presentation:
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Appendix D: Demographic Information Sheet
UNIVERSITY OF LOUISVILLE
SCHOOL OF NURSING
Please circle the appropriate response:
1. Age: 20-24

25-30

31-35

2. Race/ethnicity: Caucasian
Native American
3. Gender: Male

36-40

40-45

Hispanic/Latino

Asian/Pacific Islander

Female

4. Current Position: RN

Other
FNP

5. Years in current position: <1-2

45-50

50+

Black/African-American
Other

Prefer not to answer

Prefer not to answer

AGPCNP
3-6

6. Years in nursing related field: <1-2

Other

7-10
3-6

10 or more

7-10

11-15

16 or more

7. Prior professional experience with mental health or substance use disorders:
Yes
a. If yes how many years: <1-5

No
6-10

8. Highest degree completed: Bachelor’s Degree

10+ Not applicable
Master’s Degree
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Appendix E: Motivational Enhancement Resource Sheet
Eliciting Self- Motivating Statements:
Try to move the patient toward


Being open to suggestions or discussion about opioid use



Discussing problems related to opioid use (present or potential)



Expression of a desire to change his/her behavior

Example: Tell me what you’ve noticed about your opioid use; has it changed over time?
Affirming the Patient:
Be supportive and encouraging
Example: “I think it shows a lot of insight for you to recognize the risk to your health that
your opioid use poses.”
Responding to Resistance:
Examples of patient resistance


Defensiveness, denial, arguing



Interrupting, minimizing, changing the subject

What to do


Reflect what the patient is saying
o May prompt the opposite (desired) response



Shifting focus
o If a patient says, “I can’t quit”, then say “We are just talking, maybe
you’re not ready to quit but we can talk about ways to mitigate some of
the risk/damage”



Rolling with resistance
o Going with where the patient is- i.e. “Maybe you’ll decide you’re not
ready, but here is some information for you to look over.”
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Table 1
Mean Total Pre and Post Intervention Scores for DDPPQ, DDPPQ Subscales and NPCS

DDPPQ**

Role Adequacy**

Pre

Post

Confidence

Education

Education

Interval

Session

Session

Mean (SD)

Mean (SD)

77.75

55.75

(22.65)

(18.25)

29.24

t value

Sig. (2tailed)

11.45-32.55

4.45

<.001

20.65 (6.61)

4.81-12.37

4.82

<.001

8.06 (3.34)

5.94 (2.84

.86-3.38

3.57

.003

14.47

7.06 (3.70)

-.20-15.02

2.06

.056

(6.25)
Role Legitamcy*
Role Support

(15.44)
Motivation*

3.29 (1.49)

2.65 (1.41)

.20-1.09

3.10

.007

Role-related Self-

8.88 (3.35)

7.65 (3.41)

-.19-2.66

1.83

.085

14.19 (5.04)

11.88 (5.06)

-.32-4.94

1.87

.081

15.06

20.88

-7.25 - -4.38

-8.65

<.001

esteem
Role Support
NPCS**

* Correlation is significant at the 0.05 level (two-tailed)
** Correlation is significant at the 0.01 level (two-tailed)

STIGMA, OPIOID USE DISORDERS, AND PRIMARY CARE NP STUDENTS

40

Table 2
Correlation Among Pre and Post DDPPQ and NPCS and Prior MH/SUD Experience
1

2

3

4

1. DDPPQ Pretest

--

2. DDPPQ Posttest

.549*

--

3. NPCS Pretest

-.293

-.136

--

4. NPCS Posttest

-.354

-.483*

.679**

--

5. Prior MH/SUD

.009

-.150

.497*

.334

Experience
* Correlation is significant at the 0.05 level (two-tailed)
** Correlation is significant at the 0.01 level (two-tailed)

5

--

